Creating a Florida Cerebrovascular Disease Biorepository and Genomics Center

Mayo Clinic1 个研究点分布在 1 个国家目标入组 72 人2022年8月2日

适应症Cerebrovascular Disease Ischemic Stroke Transient Ischemic Attack Intracerebral Hemorrhage Aneurysmal Subarachnoid Hemorrhage Vascular Dementia Anoxic Brain Injury Unruptured Intracranial Aneurysm Carotid Artery Stenosis Symptomatic Asymptomatic Carotid Artery Stenosis Non-Aneurysmal Perimesencephalic Subarachnoid Haemorrhage Cerebral Venous Thrombosis Moyamoya Disease Fibromuscular Dysplasia Subarachnoid Hemorrhage Leukoaraiosis Arteriovenous Fistula Reversible Cerebral Vasoconstriction Syndrome CADASIL

概览

阶段: 不适用
干预措施: 未指定
疾病 / 适应症: Cerebrovascular Disease
发起方: Mayo Clinic
入组人数: 72
试验地点: 1
主要终点: Stroke or TIA at 12 months
状态: 进行中（未招募）
最后更新: 上个月

概览研究者入排标准结局指标研究点相似试验

概览

简要总结

The purpose of this study is to create a state-wide biorepository and resource center for cerebrovascular diseases in Florida, which will include collecting medical history information and blood from subjects affected by cerebrovascular disease. The information and blood samples collected may be used in future research for the study of cerebrovascular disease and to learn about, prevent or treat other health problems.

注册库

clinicaltrials.gov

开始日期

2022年8月2日

结束日期

2026年4月1日

最后更新

上个月

研究类型

Observational

性别

All

研究者

发起方

Mayo Clinic

责任方

Principal Investigator

主要研究者

James F. Meschia

Principal Investigator

Mayo Clinic

入排标准

入选标准

•Affected subjects with diverse cerebrovascular conditions, including, but not limited to, ischemic stroke, transient ischemic attack (TIA), intracerebral hemorrhage (ICH), aneurysmal subarachnoid hemorrhage (aSAH), vascular dementia (VAD), anoxic brain injury, unruptured intracranial aneurysm (UIA), cavernous malformation, arteriovenous malformations (AVM), carotid and vertebral arterial dissections, symptomatic and asymptomatic cervical carotid artery atherosclerotic stenosis, non-aneurysmal perimesencephalic subarachnoid hemorrhage (naSAH), cerebral venous thrombosis (CVT), moyamoya disease, fibrosmuscular dysplasia (FMD), non-traumatic, angiography-negative subarachnoid hemorrhage, leukoaraiosis, arteriovenous fistula, reversible cerebral vasoconstriction syndrome (RCVS), and CADASIL.

排除标准

•All patients with the following known or suspected virulent microorganisms causing an active or latent infection will be excluded from the study:
•Human immunodeficiency virus (HIV);
•Any viral hepatitis;
•West Nile virus (WNV);
•Influenza virus;
•Tuberculosis (TB);
•Any bacteremia;
•Any fungemia;
•Any prionopathy.